SCHEMBL8990969

SCHEMBL8990969

Fc1c[c]ccc1N=C=S

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 1/20 0.33
ALDH1A1 P00352 1/20 0.33
NR3C1 P04150 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
ADRA2A P08913 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
ADRA2C P18825 1/20 0.33
MAOA P21397 1/20 0.33
DRD1 P21728 1/20 0.33
SLC6A4 P31645 1/20 0.33
HTR2B P41595 1/20 0.33
CCR2 P41597 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MIF P14174 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17593328 0.80 CYP3A4 (0.36) ALDH1A1CYP3A4HPGDTDP1
SCHEMBL28447103 0.76 ALDH1A1 (0.33) ABCB11ALDH1A1NR3C1CYP1A2CYP3A4
SCHEMBL160878 0.70 ALDH1A1 (0.52) ABCB11ALDH1A1NR3C1CYP1A2CYP3A4
SCHEMBL30298614 0.70 ALDH1A1 (0.52) ABCB11ALDH1A1NR3C1CYP1A2CYP3A4
SCHEMBL8990792 0.70 GABRA1 (0.33) MIF
SCHEMBL7848863 0.68 APLNR (0.40) ABCB11ALDH1A1NR3C1CYP1A2CYP3A4
SCHEMBL156589 0.67 ALDH1A1 (0.38) ABCB11ALDH1A1NR3C1CYP1A2CYP3A4
SCHEMBL29564714 0.67 ALDH1A1 (0.38) ABCB11ALDH1A1NR3C1CYP1A2CYP3A4
SCHEMBL11554956 0.65 KIF11 (0.34) ABCB11ALDH1A1NR3C1CYP1A2CYP3A4
SCHEMBL57893 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0429558-B1 DIPHENYLYLETHANES AND LIQUID CRYSTALLINE PHASE MERCK PATENT GMBH (DE) 1994-03-30 EP claimed
CN-111093658-B Fused heteroaromatic-aniline compounds for the treatment of skin diseases 恩福莱克逊治疗有限公司 2022-10-14 CN disclosed
CN-113660931-A Arylaniline and heteroarylaniline compounds for the treatment of skin cancer 恩福莱克逊治疗有限公司 2021-11-16 CN disclosed
CN-113645964-A Arylaniline and heteroarylaniline compounds for use in fetal marker therapy 恩福莱克逊治疗有限公司 2021-11-12 CN disclosed
CN-111093658-A Fused heteroaromatic-aniline compounds for the treatment of skin diseases 恩福莱克逊治疗有限公司 2020-05-01 CN disclosed
US-5496499-A Biphenylethanes and liquid-crystalline phase MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1996-03-05 US disclosed
EP-0429558-B1 DIPHENYLYLETHANES AND LIQUID CRYSTALLINE PHASE MERCK PATENT GMBH (DE) 1994-03-30 EP disclosed
EP-0429558-A1 DIPHENYLYLETHANES AND LIQUID CRYSTALLINE PHASE. MERCK PATENT GMBH (DE) 1991-06-05 EP disclosed
WO-1990008757-A1 DIPHENYLYLETHANES AND LIQUID CRYSTALLINE PHASE MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1990-08-09 WO disclosed